You have 9 free searches left this month | for more free features.

bortezomib

Showing 1 - 25 of 497

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Bortezomib, Glomerulonephritis, MN Trial in Shanghai (Bortezomib)

Recruiting
  • Bortezomib
  • +5 more
  • Bortezomib
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai Jiao Tong University School of Medicin
May 19, 2022

Multiple Myeloma Trial in Rionero in Vulture (Bortezomib, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Rionero in Vulture, Potenza, Italy
    Irccs Crob
Mar 24, 2022

Lymphoma, Mantle Cell, Mantle Cell Lymphoma Trial run by the NCI (Rituximab (R), EPOCH, Bortezomib (B))

Active, not recruiting
  • Lymphoma, Mantle Cell
  • Mantle Cell Lymphoma
  • Rituximab (R)
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 21, 2021

Multiple Myeloma Trial (Iberdomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jul 18, 2022

Antibody-mediated Rejection Trial in Tehran (Bortezomib)

Recruiting
  • Antibody-mediated Rejection
  • Bortezomib
  • Tehran, Iran, Islamic Republic of
    SBMU
Jan 27, 2022

Hematological Malignancy Trial in Detroit (Bortezomib)

Recruiting
  • Hematological Malignancy
  • Bortezomib
  • Detroit, Michigan
    Henry Ford hospital
Dec 23, 2021

Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)

Active, not recruiting
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
May 9, 2022

Multiple Myeloma Trial (pomalidomide, Bortezomib, Dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jun 20, 2022

Solid Tumor, Urethral Cancer Trial in Houston (Bortezomib, Gemcitabine, Doxorubicin)

Active, not recruiting
  • Solid Tumor
  • Urethral Cancer
  • Bortezomib
  • +2 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 21, 2022

Acute Lymphoblastic Leukemia, in Relapse, Chemotherapeutic Toxicity, Minimal Residual Disease Trial in Mexico City (Bortezomib)

Recruiting
  • Acute Lymphoblastic Leukemia, in Relapse
  • +2 more
  • Bortezomib
  • Mexico City, Mexico
    Hospital General de México "Dr. Eduardo Liceaga"
Jan 2, 2022

Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
Dec 3, 2021

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Nov 30, 2021

Multiple Myeloma Trial in Chicago, Milwaukee (Bortezomib, Isatuximab, Cyclophosphamide)

Recruiting
  • Multiple Myeloma
  • Bortezomib
  • +3 more
  • Chicago, Illinois
  • +1 more
Mar 14, 2022

Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, Bortezomib)

Recruiting
  • Graft-versus-host Disease
  • New York, New York
    NYU Langone Health
Mar 24, 2022

Lung Diseases, Interstitial, Systemic Sclerosis, Scleroderma Trial in Chicago (Bortezomib, Placebo, Mycophenolate mofetil)

Completed
  • Lung Diseases, Interstitial
  • +2 more
  • Bortezomib
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 2, 2021

Chronic Myeloid Leukemia (CML), Pancreatic Ca, Colon/Rectal Ca Trial run by the National Heart, Lung, and Blood Institute

Completed
  • Chronic Myeloid Leukemia (CML)
  • +4 more
  • Bortezomib
  • NK cells
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Recruiting
  • Plasma Cell Myeloma
  • Bortezomib
  • +3 more
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Dec 16, 2021

Multiple Myeloma, Myeloma Trial in Poitiers (Isatuximab, Lenalidomide, Bortezomib)

Recruiting
  • Multiple Myeloma
  • Myeloma
  • Poitiers, France
    CHU Poitiers
Apr 19, 2022

Multiple Myeloma and Plasma Cell Tumor, Neurotoxicity Trial in Duarte (drug, genetic, other, procedure)

Completed
  • Multiple Myeloma and Plasma Cell Neoplasm
  • Neurotoxicity
  • bortezomib
  • +9 more
  • Duarte, California
    City of Hope Medical Center
Aug 17, 2021

Multiple Myeloma Trial in United States (Lenalidomide, Elotuzumab, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Atlanta, Georgia
  • +6 more
Dec 17, 2021

Multiple Myeloma in Relapse Trial in Boston, Durham (Panobinostat, Dexamethasone, Lenalidomide)

Completed
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
  • +3 more
Sep 3, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Rochester (Bortezomib, Metformin Hydrochloride,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Bortezomib
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 6, 2021

Multiple Myeloma Trial in Westwood (Bortezomib, Granulocyte colony-stimulating factor (G-CSF), Mozobil)

Completed
  • Multiple Myeloma
  • Bortezomib
  • +2 more
  • Westwood, Kansas
    The University of Kansas Medical Center
May 24, 2021

Multiple Myeloma Trial in United States (Elotuzumab, Pomalidomide, Bortezomib)

Active, not recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +5 more
Oct 28, 2021

Multiple Myeloma Trial in United States (Bortezomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Bortezomib
  • +2 more
  • Denver, Colorado
  • +7 more
Feb 11, 2022